FULVICIN U/F PWR DIN 00332259
Health Canada record
| Active ingredient(s) | GRISEOFULVIN 2.5 G |
|---|---|
| Dosage form | Powder |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1975 |
| Current status date | 04-Aug-2009 |
| Source | Health Canada DPD |
Establishment licence of the holder
Schering-Plough Mexico S.A. DE C.V. — licence , not currently licensed, last inspection rating C (2022-08-29).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing GRISEOFULVIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00513237 | FULVICIN PG TAB 330MG | SCHERING-PLOUGH CANADA INC | Tablet | GRISEOFULVIN 330 MG | Cancelled Post Market |
| 00028274 | FULVICIN U/F TAB 250MG | SCHERING-PLOUGH CANADA INC | Tablet | GRISEOFULVIN 250 MG | Cancelled Post Market |
| 00028282 | FULVICIN UF TAB 500MG | SCHERING-PLOUGH CANADA INC | Tablet | GRISEOFULVIN 500 MG | Cancelled Post Market |
| 00012246 | GRISOVIN FP TAB 125MG | GLAXO CANADA INC | Tablet | GRISEOFULVIN 125 MG | Cancelled Post Market |
| 00012254 | GRISOVIN FP TAB 250MG | GLAXO CANADA INC | Tablet | GRISEOFULVIN 250 MG | Cancelled Post Market |
| 00012262 | GRISOVIN FP TAB 500MG | GLAXO CANADA INC | Tablet | GRISEOFULVIN 500 MG | Cancelled Post Market |
| 02100266 | GRISOVIN-FP 125MG TAB | ROBERTS PHARMACEUTICAL CANADA INC. | Tablet | GRISEOFULVIN 125 MG | Cancelled Post Market |
| 02100274 | GRISOVIN-FP 250MG TAB | ROBERTS PHARMACEUTICAL CANADA INC. | Tablet | GRISEOFULVIN 250 MG | Cancelled Post Market |
International API supply for GRISEOFULVIN
1 valid EDQM Certificates of Suitability from 1 holders. 1 active FDA Drug Master Files.
Request a quote for FULVICIN U/F PWR